Cargando…

Pharmacogenetics of Statin-Induced Myotoxicity

Statins, a class of lipid-lowering medications, have been a keystone treatment in cardiovascular health. However, adverse effects associated with statin use impact patient adherence, leading to statin discontinuation. Statin-induced myotoxicity (SIM) is one of the most common adverse effects, preval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kee, Ping Siu, Chin, Paul Ken Leong, Kennedy, Martin A., Maggo, Simran D. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596698/ https://www.ncbi.nlm.nih.gov/pubmed/33193687 http://dx.doi.org/10.3389/fgene.2020.575678

Ejemplares similares

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
por: Kee, Ping Siu, et al.
Publicado: (2023)

Phenotype Standardization for Statin-Induced Myotoxicity
por: Alfirevic, A, et al.
Publicado: (2014)

The role of acid-base imbalance in statin-induced myotoxicity
por: Taha, Dhiaa A., et al.
Publicado: (2016)

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus
por: Kee, Ping Siu, et al.
Publicado: (2022)

Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
por: Wiley, Laura K., et al.
Publicado: (2015)

Notch Target Gene E(spl)mδ Is a Mediator of Methylmercury-Induced Myotoxicity in Drosophila
por: Prince, Lisa M., et al.
Publicado: (2018)

Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity
por: Panajatovic, M, et al.
Publicado: (2020)

Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples
por: Hitchman, Leonie M., et al.
Publicado: (2022)

Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects
por: Maggo, Simran, et al.
Publicado: (2019)

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)

Nelarabine Associated Myotoxicity and Rhabdomyolysis
por: Haider, Mahnur, et al.
Publicado: (2015)

Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies: An Observational Study in Japan
por: Watanabe, Yurika, et al.
Publicado: (2015)

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial
por: Shah-Williams, Ebony, et al.
Publicado: (2020)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2015)

Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2016)

Metabolic effects as a cause of myotoxic effects of fluoroquinolones
por: Metterlein, Thomas, et al.
Publicado: (2015)

Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
por: Ramakumari, Nuthalapati, et al.
Publicado: (2018)

Revisiting Secondary Information Related to Pharmacogenetic Testing
por: Haga, Susanne B.
Publicado: (2021)

Myotoxicity of telbivudine in pre-existing muscle damage
por: Finsterer, Josef, et al.
Publicado: (2010)

Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved
por: Gawronski, Brian E., et al.
Publicado: (2023)

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
por: Rigter, Tessel, et al.
Publicado: (2020)

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018)

The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety
por: Ching, Nathan R, et al.
Publicado: (2018)

Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility
por: Ma, Lulin, et al.
Publicado: (2022)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
por: den Uil, Manon G., et al.
Publicado: (2023)

Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
por: Richardson, Marty, et al.
Publicado: (2019)

Myotoxic Mushroom Poisoning in Thailand: Clinical Characteristics and Outcomes
por: Trakulsrichai, Satariya, et al.
Publicado: (2020)

Impact of porous microsponges in minimizing myotoxic side effects of simvastatin
por: Ali, Ahmed U., et al.
Publicado: (2023)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Literature Review Concerning the Challenges of Implementing Pharmacogenetics in Primary Care Practice
por: Omer, Mohamed S
Publicado: (2020)

The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
por: Maggo, Simran D.S., et al.
Publicado: (2019)

Geranylgeraniol Prevents Statin-Dependent Myotoxicity in C2C12 Muscle Cells through RAP1 GTPase Prenylation and Cytoprotective Autophagy
por: Jaśkiewicz, Anna, et al.
Publicado: (2018)

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
por: Jameson, Adam, et al.
Publicado: (2021)

Psychiatric mental health nurse practitioner student knowledge and perceptions of pharmacogenetic testing
por: Kaltenrieder, Corrina M., et al.
Publicado: (2023)

Comment on: Bilateral lateral rectus myotoxicity after retrobulbar anesthesia
por: Nayak, Madhurima K
Publicado: (2016)

Response to: Bilateral lateral rectus myotoxicity after retrobulbar anesthesia
por: Kim, Chung-Hwan, et al.
Publicado: (2016)

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
por: Lee, Su-Jun
Publicado: (2013)

Measurement of bupivacaine induced myotoxicity in interfascial plane blocks: A randomised controlled trial
por: Rakhi, Vasundhara, et al.
Publicado: (2021)

The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
por: Trompet, Stella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8g5aambbp2c432f47c7jlufmpp